Home > ECF 2020 Highlights Podcast

ECF 2020 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom

Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 138

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 138

Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 174

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 174

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 175
Conference
ECF 2020
  Dr Rachel Giles guides us through 6 abstracts from the European Charcot Foundation 28th Annual Meeting: No association between Ig levels and infection in ofatumumab-treated patients - Wiendl et al. First long-term efficacy data of a BTK inhibitor - Montalban et al. Reliable and convenient method to assess cognitive function in MS patients - Miyazaki et al. Real-world efficacy of ocrelizumab in MS patients - Eggebrecht et al. Long-term safety and efficacy of ozanimod in relapsing MS - Selmaj et al. Superior effect of ponesimod versus teriflunomide on clinical disease activity and MRI-based outcomes - Kappos et al.


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on